| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |